Societal indicators of lung cancer screening behaviours

New therapeutic options in advanced and metastatic breast cancer

In vitro diagnostic models for ALL: what can we learn on actionable targets?

Latest concepts in the diagnosis of genetic ALL subtypes

Can we reduce the intensity of frontline therapy?

Novel therapies for paediatric B-ALL

Immunological monitoring of patients receiving immunotherapy

Combining MRD quantitation and genetics in post-remission risk stratification

Management of relapsed T-ALL in children

Optimal use of TKIs for therapy of Ph-positive ALL

Bispecific T-cell engaging therapy for adult ALL

For HSCT in Ph-positive ALL